DE60131733D1 - Verfahren zur herstellung von (2s,3r,4s)-4-hydroxyisoleucin und analoga - Google Patents

Verfahren zur herstellung von (2s,3r,4s)-4-hydroxyisoleucin und analoga

Info

Publication number
DE60131733D1
DE60131733D1 DE60131733T DE60131733T DE60131733D1 DE 60131733 D1 DE60131733 D1 DE 60131733D1 DE 60131733 T DE60131733 T DE 60131733T DE 60131733 T DE60131733 T DE 60131733T DE 60131733 D1 DE60131733 D1 DE 60131733D1
Authority
DE
Germany
Prior art keywords
group
preparing
hydroxyisoleucine
analogue
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60131733T
Other languages
English (en)
Other versions
DE60131733T2 (de
Inventor
Jamal Ouazzani
Pierre Potier
Nobumichi Andre Sasaki
Wang Qian Zhu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Original Assignee
Centre National de la Recherche Scientifique CNRS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS filed Critical Centre National de la Recherche Scientifique CNRS
Publication of DE60131733D1 publication Critical patent/DE60131733D1/de
Application granted granted Critical
Publication of DE60131733T2 publication Critical patent/DE60131733T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/30—Preparation of optical isomers
    • C07C227/32—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/24—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton
    • C07C255/26—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the same saturated acyclic carbon skeleton containing cyano groups, amino groups and singly-bound oxygen atoms bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02—Sulfinic acids; Derivatives thereof
    • C07C313/06—Sulfinamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
DE60131733T 2000-03-27 2001-03-23 Verfahren zur herstellung von (2s,3r,4s)-4-hydroxyisoleucin und analoga Expired - Lifetime DE60131733T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0003859 2000-03-27
FR0003859A FR2806726B1 (fr) 2000-03-27 2000-03-27 Procede de preparation de la (2s,3r,4s)-4-hydroxyisoleucine et de ses analogues
PCT/FR2001/000885 WO2001072688A2 (fr) 2000-03-27 2001-03-23 Procede de preparation de la (2s,3r,4s)-4-hydroxyisoleucine et de ses analogues

Publications (2)

Publication Number Publication Date
DE60131733D1 true DE60131733D1 (de) 2008-01-17
DE60131733T2 DE60131733T2 (de) 2008-10-30

Family

ID=8848534

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60131733T Expired - Lifetime DE60131733T2 (de) 2000-03-27 2001-03-23 Verfahren zur herstellung von (2s,3r,4s)-4-hydroxyisoleucin und analoga

Country Status (8)

Country Link
US (2) US20030219880A1 (de)
EP (1) EP1268397B1 (de)
AT (1) ATE380173T1 (de)
AU (1) AU4663301A (de)
CA (1) CA2404621C (de)
DE (1) DE60131733T2 (de)
FR (1) FR2806726B1 (de)
WO (1) WO2001072688A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003088947A1 (en) * 2002-04-22 2003-10-30 Experimental & Applied Sciences, Inc. Food supplements containing 4-hydroxyisoleucine and creatine
FR2854629B1 (fr) * 2003-05-07 2005-06-17 Centre Nat Rech Scient Procede de synthese de la 4-hydroxyisoleucine et de ses derives
EP1657236A1 (de) * 2004-11-10 2006-05-17 Centre National De La Recherche Scientifique (Cnrs) Verfahren zur Herstellung von Diastereoisomeren von 4-Hydroxyisoleucin
AU2006245438A1 (en) * 2005-02-18 2006-11-16 Bellus Health (Innodia) Inc. Analogs of 4-hydroxyisoleucine and uses thereof
CA2600954A1 (en) * 2005-03-22 2006-12-14 Innodia Inc. Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
US20100048545A1 (en) * 2006-03-22 2010-02-25 Innodia Inc. Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity
WO2012162507A1 (en) 2011-05-24 2012-11-29 Apicore, Llc Process for preparing saxagliptin and its novel intermediates useful in the synthesis thereof
CN104152505B (zh) * 2014-08-08 2016-11-23 江南大学 一种利用重组菌株转化制备4-羟基-l-异亮氨酸的方法
CN105566136A (zh) * 2016-01-19 2016-05-11 天津科技大学 一种从发酵液中分离提取4-羟基异亮氨酸的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2745718B1 (fr) * 1996-03-08 1998-05-07 Gestion Jouvenet Soc Civ De Composition antidiabetique a base de 4-hydroxyisoleucine

Also Published As

Publication number Publication date
US20030219880A1 (en) 2003-11-27
ATE380173T1 (de) 2007-12-15
CA2404621C (fr) 2012-11-20
US20050079587A1 (en) 2005-04-14
EP1268397A2 (de) 2003-01-02
EP1268397B1 (de) 2007-12-05
US7432087B2 (en) 2008-10-07
WO2001072688A2 (fr) 2001-10-04
CA2404621A1 (fr) 2001-10-04
AU4663301A (en) 2001-10-08
WO2001072688A3 (fr) 2002-04-11
FR2806726A1 (fr) 2001-09-28
DE60131733T2 (de) 2008-10-30
FR2806726B1 (fr) 2003-01-03

Similar Documents

Publication Publication Date Title
IS6257A (is) Frumuviðloðunartálmar
DE68928042D1 (de) Verwendung von Peptidase-Hemmer zur Herstellung von Medikamenten für die Behandlung von Schlaganfällen
DE69207194D1 (de) Verfahren zur Herstellung von Bacchatin III und von Desacetyl-10-Bacchatin III Derivate
ATE410412T1 (de) Oxopyrrolidin verbindungen, verfahren zur herstellung dieser verbindungen und deren verwendung zur herstellung von levetiracetam und analogen
DE60131733D1 (de) Verfahren zur herstellung von (2s,3r,4s)-4-hydroxyisoleucin und analoga
DE60309251D1 (de) Verfahren zur Herstellung von Donepezil
DE69614824D1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
DE59509910D1 (de) Verfahren zur Herstellung von Alkylhydrogenchlorsilanen
DE59606057D1 (de) Verfahren zur herstellung von dihydroxypyrimidin-derivaten
DE50107981D1 (de) Verfahren zur reinigung von abgasströmen
ATE201022T1 (de) Verfahren zur herstellung von schwefelhaltigen imidazolderivaten und erhaltene zwischenprodukte
DE602004031129D1 (de) Verfahren zur herstellung von quetiapin
DE60133395D1 (de) Verfahren zur herstellung von alpha'-chlorketonen
DE60003169D1 (de) Verfahren zur herstellung von [s-(r*,s*)]-g(b)-[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl] amino]-3-pyridinpropansäurederivate
DE69911689D1 (de) Verfahren zur Herstellung von S-Aryl-L-cystein und Derivate
DE50105413D1 (de) Verfahren zur Racemisierung von optisch aktiven Aminen
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
DE69721055D1 (de) Verfahren zur herstellung von depsipeptiden und zwischenprodukten davon
DE60308204D1 (de) Verfahren zur herstellung von aminopyrrolidinderivaten
ATE342250T1 (de) Verfahren zur herstellung von (aminomethyl)trifluoromethylcarbinol-derivaten
DE60015177D1 (de) Verfahren zur herstellung von 2-[4-(alpha-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxyessigsäure und zwischenprodukte dafür
DE60306361D1 (de) Verfahren zur herstellung von benazeprilhydrochloride
ATE473208T1 (de) Isodipeptid als syntheseeinheit zur herstellung von peptiden
ATE187958T1 (de) Verfahren zur herstellung von levobupivacain und analogue aus l-lysin
ATE208388T1 (de) Eintopfverfahren zur herstellung von 2- oxazolidinonderivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition